Elite Pharmaceuticals (ELTP) Change in Accured Expenses (2010 - 2026)
Elite Pharmaceuticals (ELTP) reported Change in Accured Expenses of -$3.76 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with $786,516 a year earlier.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Elite Pharmaceuticals' Change in Accured Expenses came in at $1.85 million; for FY2026 (ended Mar 31, 2026), it came in at $6.4 million.
- By fiscal year, Change in Accured Expenses came in at -$1.51 million in FY2025, $7.76 million in FY2024 (+480.5%), $1.34 million in FY2023 (+325.4%) and $314,214 in FY2022.
- The fiscal Q1 2027 figure ranks as the lowest quarterly Change in Accured Expenses in data going back to fiscal Q1 2011.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $4.65 million (Q4 2026), -$604,521 (Q3 2026) and $1.57 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | - |
| 10 | Elite Pharmaceuticals | 244.53 Mn | 126.20 Mn | 13.51 Mn | -3.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.76 Mn |
| Mar 31, 2026 | 4.65 Mn |
| Dec 31, 2025 | -604,521.00 |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 786,516.00 |
| Mar 31, 2025 | 76,214.00 |
| Dec 31, 2024 | -1.98 Mn |
| Sep 30, 2024 | -524,631.00 |
| Jun 30, 2024 | 926,348.00 |
| Mar 31, 2024 | 4.08 Mn |
| Dec 31, 2023 | -366,387.00 |
| Sep 30, 2023 | 3.16 Mn |
| Jun 30, 2023 | 881,435.00 |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | -584,403.00 |
| Sep 30, 2022 | -25,515.00 |
| Jun 30, 2022 | 299,968.00 |
| Mar 31, 2022 | 688,034.00 |
| Dec 31, 2021 | -471,544.00 |
| Sep 30, 2021 | -633,842.00 |
API Access
Elite Pharmaceuticals Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();